Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| R21AI158296 | Validation and characterization of Tat inhibitors identified through HTS | 1 | 2022 |
| R21AI161306 | mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices | 1 | 2022 |
| R25CA134283 | University of Louisville Cancer Education Program | 1 | 2022 |
| R35CA200422 | Molecular Basis of KSHV oncogenesis | 1 | 2022 |
| R35GM126922 | Redox control over metabolism and mitochondrial bioenergetics directs the course of acute inflammation and sepsis. | 1 | 2022 |
| R35GM128802 | Regulation of Protein Production Dynamics:RNA Binding Proteins and the Ribosome Code | 1 | 2022 |
| R50CA232985 | Targeting the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer | 1 | 2022 |
| T32AI052066 | Molecular Pathogenesis of Infectious Diseases | 1 | 2022 |
| T32GM008284 | Molecular Biophysics Training Grant | 1 | 2022 |
| T32GM080189 | The Chemistry-Biology Interface Program at Johns Hopkins University | 1 | 2022 |
| T32GM127253 | Scholars in BioMedical Sciences (SBMS) Training Program | 1 | 2022 |
| U01HG007690 | Center for Integrated Approached to Undiagnosed Diseases | 1 | 2022 |
| U54CA244438 | UCSF Center for Synthetic Immunology: Tools to Reprogram the Immune System to Combat Cancer | 1 | 2022 |
| T32GM007753 | Medical Scientist Training Program | 4 | 2021 |
| P41GM103533 | Comprehensive Biology: Exploiting the Yeast Genome | 3 | 2021 |
| P30DK034933 | University of Michigan Center for Gastrointestinal Research | 2 | 2021 |
| R00DE026856 | Novel Candida albicans host receptors during infection and immune response | 2 | 2021 |
| R01AI052201 | Innate Immune Mechanisms of Non-infectious Lung Inflammation | 2 | 2021 |
| R01GM127602 | The function of Topoisomerase I SUMOylation in transcription and chemoresistance | 2 | 2021 |
| T32DA007097 | Training in PharmacoNeuroImmune Substance Abuse Research | 2 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=19